课题基金 / 基金详情

项目摘要

项目成果

James Mitchell的其他基金

相似基金

相关文献

中文摘要
翻译
在这个项目中使用了两个品系的小鼠。将雌性C3 H和CBA小鼠暴露于3戈伊的总辐射剂量,在动物食物中添加或不添加Tempol。在辐射暴露后,立即将动物置于对照或含TP的食物上。各组包括:a)无辐射,对照食物,B)3戈伊,对照食物,c)无辐射,TP食物,和d)3戈伊,TP食物。对于C3 H小鼠,增加一个接受3戈伊全身照射的额外组,其中在照射后延迟一个月给予含TP的食物。初步数据显示,辐射后TP食物补充:a)与对照食物饮食的动物相比,没有改变食物消耗,B)与对照食物饮食的动物相比,TP饮食导致两种小鼠品系的体重降低(C3 H为40%,CBA为20%),以及c)辐射后TP食物补充显著提高了两种小鼠品系的存活率。0戈伊、3戈伊、0戈伊TP和3戈伊TP对C3 H小鼠的中位生存值分别为706、434、764和670天。对于CBA小鼠,0戈伊、3戈伊、0戈伊TP和3戈伊TP(C3 H小鼠)的中位存活值分别为901、660、939和782天。造血肿瘤(主要是淋巴瘤)的发病率显着降低,在两种小鼠品系的TP治疗和实体肿瘤的发病率显着降低与TP治疗CBA小鼠。这些初步数据将鼓励进一步研究和开发TP作为一种化学预防剂。 第二个假设也正在测试中,即通过在辐射暴露前立即给予辐射保护剂来保护小鼠免受致死性全身辐射,将增加癌症诱导的风险。将小鼠暴露于10.8戈伊的全身辐射剂量,该辐射剂量导致100%致死。在10.8戈伊暴露前10分钟,将对动物注射辐射防护剂。作为该组的对照,另一组动物暴露于5.4戈伊全身照射。当在全身照射前10分钟给予辐射防护剂时,该辐射剂量源自辐射剂量修正因子(2)。还将在这些动物的整个生命周期内跟踪其肿瘤诱导,如上所述。初步数据显示,接受0、5.4或10.8戈伊照射的小鼠的中位生存期分别为706、460和491天。5.4和10.8戈伊组之间无差异(p = 0.42);然而,两个辐照组的中位生存期均显著短于未辐照小鼠(p 0.0001)。5.4和10.8戈伊组的癌症发病率(造血细胞肿瘤加实体瘤)相似,并且显著高于未照射对照组。然而,两组之间造血肿瘤与实体肿瘤的比率不同,5.4戈伊组的造血肿瘤发生率高于10.8戈伊组(1.8倍)。在10.8戈伊组中观察到实体瘤的发生率更高。这些初步结果表明,与未受辐射的对照组相比,受致死性全身辐射保护的小鼠寿命缩短,这在很大程度上是由于辐射后的癌症诱导。最后,已开始进行研究,以确定接受全身辐射的小鼠尿液中的代谢物是否可以在观察肿瘤质量之前预测辐射诱发的癌症诱发。
英文摘要
Two strains of mice were used in this project. Female C3H and CBA mice were exposed to a total body dose of radiation of 3 Gy with or without Tempol supplementation in the animal's food. Immediately following the radiation exposure, animals were be placed on either control or TP-containing food. The groups include: a) no radiation, control food, b) 3 Gy, control food, c) no radiation, TP food, and d) 3 Gy, TP food. For C3H mice, one additional group was added receiving 3 Gy total body irradiation where the administration of the TP containing food was delayed one month post-irradiation. Preliminary data show TP food supplementation after radiation: a) did not alter food consumption compared to animals on a control food diet, b) compared to animals on control food diet, the TP diet resulted in decreased weights in both mouse strains (40% for C3H and 20% for CBA), and c) TP food supplementation post-radiation significantly enhanced the survival of both mouse stains. Median survival values for 0 Gy, 3 Gy, 0 Gy TP, and 3 Gy TP for C3H mice was 706, 434, 764, and 670 days, respectively. For CBA mice median survival values for 0 Gy, 3 Gy, 0 Gy TP, and 3 Gy TP for C3H mice was 901, 660, 939, and 782 days, respectively. The incidence of hematopoietic neoplasms (predominantly lymphomas) was significantly reduced in both mouse strains by TP treatment and both the onset and incidence of solid neoplasms was significantly reduced in CBA mice treated with TP. These preliminary data would encourage further research and development of TP as a chemopreventive agent. The second hypothesis is also being tested that mice protected from lethal total body irradiation by administration of a radioprotector immediately before radiation exposure will experience an elevated risk of cancer induction. Mice were exposed to a total body radiation dose of 10.8 Gy, a radiation dose that results in 100% lethality. Ten minutes prior to the 10.8 Gy exposure the animals will be injected with a radioprotector. The control for this group, another set of animals was exposed to 5.4 Gy total body irradiation. This radiation dose was derived from the radiation dose modification factor (2) when the radioprotector is administered 10 min before total body irradiation. These animals will also be followed for their entire lifespan for tumor induction as outlined above. Preliminary data show that the median survival for mice receiving 0, 5.4 or 10.8 Gy were 706, 460, and 491 days, respectively. There was no difference between the 5.4 and 10.8 Gy groups (p = 0.42); however, the median survival of both irradiated groups was significantly shorter compared to unirradiated mice (p < 0.0001). Cancer incidence (hematopoietic plus solid tumors) was similar between the 5.4 and 10.8 Gy groups and was significantly greater than for unirradiated controls. However, the ratio of hematopoietic to solid tumors differed between the two groups, with the 5.4 Gy group having a higher incidence of hematopoietic neoplasms compared to the 10.8 Gy group (1.8 fold). A greater incidence of solid tumors was observed in the 10.8 Gy group. These preliminary results suggest that mice protected from lethal whole body radiation have a shortened lifespan, due in large part, to cancer induction post-radiation compared to unirradiated controls. Lastly studies have been initiated to determine if metabolites in the urine of mice receiving whole body radiation can predict for radiation-induced cancer induction prior to the observation of tumor mass.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nitroxides as Protectors Against Oxidative Stress
Modulation of Therapeutic Response
Modulation of Therapeutic Response
Modulation of Therapeutic Response
海外基金